Kristen Coppock, MA, Editor

At the American Pharmacy Purchasing Alliance's PharmCon, Michael Castagna, PharmD, MBA, and CEO of Mannkind Corporation discussed the need for a larger focus on patient outcomes in order to better address the diabetes pandemic occurring in the United States.

At the American Pharmacy Purchasing Alliance’s PharmCon in Orlando, FL, experts with collaborative practice experience discussed why these pharmacist-physician partnerships are useful, and how they can effectively work.

During a presentation at the American Pharmacy Purchasing Alliance's Pharmacon in Orlando, FL, several panelists discussed the use of nutraceuticals in managing conditions like chronic pain.

Change is needed to create a better working relationship between pharmacy benefit managers (PBMs) and independent pharmacies, according to a panel of experts at the American Pharmacy Purchasing Alliance (APPA) conference in Orlando, FL.

Pegfilgrastim-jmdb is the first biosimilar to pegfilgrastim (Neulasta) approved by the FDA.

The FDA has approved pegfilgrastim-jmdb (Fulphila, Mylan GmbH) as the first biosimilar to pegfilgrastim (Neulasta) to help reduce the chance of fever-causing infection for a population of patients with cancer.

New policies that aim to help generic drug makers move their products through the development and approval processes more efficiently have been announced by FDA Commissioner Scott Gottlieb, MD.

New policies that aim to help generic drug makers move their products through the development and approval processes more efficiently have been announced by FDA Commissioner Scott Gottlieb, MD.

TherapeuticsMD announced it has received FDA approval for IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.

Novel enzyme therapy for adults with PKU, a rare genetic disease, has won approval from the agency.

The FDA is taking new steps to ensure products being marketed to protect consumers from the sun’s harmful effects deliver on their promises, starting with warning letters sent to companies marketing products with unproven claims.

The FDA is taking new steps to ensure products being marketed to protect consumers from the sun’s harmful effects deliver on their promises, as it recognizes No Fry Day.

The FDA has announced its approval of avatrombopag (Doptelet, AkaRx) tablets to treat low blood platelet count in adults with chronic liver disease (CLD) who are scheduled to undergo a medical or dental procedure.

The FDA has announced its approval of avatrombopag (Doptelet, AkaRx) tablets to treat low blood platelet count in adults with chronic liver disease.

Serious cases of neural tube birth defects, including spina bifida, have been reported in babies born to women with HIV being treated with dolutegravir.

The FDA approved lofexidine hydrochloride (Lucemyra) for the mitigation of opioid withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults, aged 18 and older.

The FDA has approved lofexidine hydrochloride (Lucemyra) for the mitigation of opioid withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

Pharmacists can help identify pharmaceuticals that could trigger symptoms in those with the autoimmune condition.

The approval follows a review of scientific evidence, including a clinical study of 24 patients that evaluated daytime and nighttime driving performance while wearing the lenses.

Three deaths are among 107 reported incidences of individuals who experienced severe bleeding after using synthetic cannabinoids.

Multiple incidences of severe bleeding prompted has prompted the Illinois Department of Public Health (IDPH) to issue a warning this week about the dangers of synthetic cannabinoids.

Acetaminophen overuse becomes much more common in the United States during cold and flu season, according to a recently published study.

Pharmacy benefit managers would be required to obtain a license from the state to do business in Arkansas, under proposed legislation announced Wednesday.

An unusually high rate of hospitalizations of nonelderly adults seen with widespread influenza activity.

Influenza activity is breaking recent records this season, and is not yet slowing down, according to the CDC.